Question:
V. USP requirements and FDA guidance for modified-release dosage forms
Author: Dwight ObillosAnswer:
1) Drug release 2) Uniformity of dosage units 3) In vitro/in vivo correlations (IVIVCs) 4) Labeling
0 / 5 Â (0 ratings)
1 answer(s) in total